Search | Webyourself Social Media Platform

Dhanashri Patil added article Health
2024-03-26 12:47:23 -

Advancing Precision Oncology: Exploring Biomarkers For PARP Inhibitor Therapy In Cancer Treatment
Precision medicine aims to match the right treatment to the right patient based on the molecular characteristics of their cancer. PARP inhibitors are one type of targeted therapy that has shown promise in certain breast and ovarian cancers linked to defective DNA repair pathways. However, identifying predictive biomarkers remains an active area of research to optimize patient selection and...

0 Comments 0 Shares 1717 Views 0 Reviews

Please log in to like, share and comment!
Pooja Salve added article Health
2023-09-20 11:20:40 -

Global PARP Inhibitor Biomarkers Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer & Rising Demand for Personalized Medicine
The Global PARP Inhibitor Biomarkers Market is estimated to be valued at US$ 907.1 million in 2023 and is expected to exhibit a CAGR of 24.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The PARP Inhibitor Biomarkers market is experiencing significant growth due to the increasing incidence of cancer worldwide. PARP...

0 Comments 0 Shares 1782 Views 0 Reviews

Please log in to like, share and comment!
Poojacmi Salve added article Health
2023-08-18 06:44:51 -

Global PARP Inhibitor Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer and Rising Geriatric Population
The global PARP Inhibitor Market is estimated to be valued at USD 6.60 billion in 2022 and is expected to exhibit a CAGR of 13.09% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:PARP inhibitors are a class of drugs that inhibit the activity of Poly (ADP-ribose) polymerase (PARP) enzymes in the body. These enzymes play...

0 Comments 0 Shares 2512 Views 0 Reviews

Please log in to like, share and comment!
Ashwini Bakhade added article Other
2024-02-22 11:47:21 -

PARP Inhibitor Biomarkers - The Key to Precision Cancer Treatment
Precision oncology has revolutionized cancer treatment in recent years with the introduction of targeted therapies that rely on identifying specific biomarkers. Poly ADP-ribose polymerase or PARP inhibitors are a class of targeted drugs that have shown great promise in certain cancers associated with DNA repair deficiencies. However, like other targeted therapies, identifying the right patients...

0 Comments 0 Shares 1198 Views 0 Reviews

Please log in to like, share and comment!
Raj Kumar Dhote added article Health
2023-12-27 13:05:47 -

PARP Inhibitor Biomarkers Market Are Estimated To Witness High Growth Owing To Rising Demand As Companion Diagnostics
PARP (Poly ADP-Ribose Polymerase) inhibitor biomarkers are used for the stratification of patients with certain cancers like breast and ovarian cancer into those likely to respond to PARP inhibitor treatment and those unlikely to respond. They play an important role as companion diagnostics alongside PARP inhibitors drugs to identify patients with homologous recombination deficiency (HRD)...

0 Comments 0 Shares 1237 Views 0 Reviews

Please log in to like, share and comment!
Naufan Cmi added article Other
2024-02-27 12:27:15 -

PARP Inhibitor Biomarkers Market is Anticipated to Witness High Growth Owing to Increased Adoption of Precision Medicine
PARP inhibitor biomarkers are essential diagnostic tools for cancer treatment and identifying response rates to PARP inhibitor therapies. PARP inhibitors are increasingly used for the treatment of metastatic cancers with BRCA mutations. These inhibitors are primarily used for treating cancers like ovarian, breast, and prostate cancers. Rising cancer prevalence worldwide drives the adoption of...

0 Comments 0 Shares 1066 Views 0 Reviews

Please log in to like, share and comment!
Pooja Salve added article Health
2024-01-03 11:07:23 -

PARP Inhibitor Market is Estimated to Witness High Growth Owing to Increasing Adoption in Oncology Treatment
Market Dynamics Increasing adoption in oncology treatment: The key driver for the growth of the PARP inhibitor market is its increasing adoption in the treatment of various cancers like breast and ovarian cancers. As per the National Cancer Institute, PARP inhibitors have shown promising results in slowing or stopping the growth of cancer cells with BRCA1 or BRCA2 gene mutations. This is...

0 Comments 0 Shares 1218 Views 0 Reviews

Please log in to like, share and comment!

More Results